Detailseite
Projekt Druckansicht

Untersuchung von in der gastrischen X/A-ähnlichen Zelle des Magens produziertem Nesfatin-1 auf ängstliches Verhalten/Angsterleben im Tiermodell und beim Menschen.

Fachliche Zuordnung Endokrinologie, Diabetologie, Metabolismus
Ernährungswissenschaften
Gastroenterologie
Förderung Förderung von 2012 bis 2017
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 216245554
 
Erstellungsjahr 2023

Zusammenfassung der Projektergebnisse

The present studies give novel insight into the occurrence and function of two novel gastrointestinal peptide hormones, NUCB2/nesfatin-1 and phoenixin, in animal models and in human. Firstly, NUCB2/nesfatin-1 was shown to be increased in the blood of rats due to immobilization stress and able to affect (increase) anxiety in normal-weight rats. Moreover, also in human subjects nesfatin-1 in the blood was elevated due to acute stress in normal-weight females, while in obese women this was not the case. Additionally, in women with obesity that suffered from high anxiety NUCB2/nesfatin-1 in the blood was higher than in obese women with low anxiety. Furthermore, phoenixin-14 was demonstrated to increase food intake in rats by reducing satiety. It was also shown that this peptide activates various regions in the brain, among others brain areas where NUCB2/nesfatin-1 has been detected. Finally, brain regions where phoenixin-14 is detected are activated by different stressors and immobilization or inflammation stress increased phoenixin expression. NUCB2/nesfatin-1 and phoenixin both play a role in stress and anxiety regulation and thus might represent therapeutic targets in the treatment of stress-related diseases and anxiety disorders; this should be further followed up in a translational approach.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung